Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Maxwell

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Oncotarget|August 29, 2015
Automated tumor analysis for molecular profiling in lung cancerPeter W Hamilton, Yinhai Wang, Clinton Boyd, et al.
British Journal of Cancer|June 9, 2017
Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapiesMuhammad A Alvi, Maurice B Loughrey, Philip Dunne, et al.
Oncotarget|August 29, 2015
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utilityMuhammad A Alvi, Darragh G McArt, Paul Kelly, et al.
Oncotarget|April 19, 2017
Erythropoietin drives breast cancer progression by activation of its receptor EPORKa Kui Chan, Kyle B Matchett, Jonathan A Coulter, et al.
British Journal of Haematology|October 7, 2014
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementationPerry Maxwell, Florinda Melendez-Rodríguez, Kyle B Matchett, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Nature Communications|July 7, 2023
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.
Oncotarget|August 29, 2015
Automated tumor analysis for molecular profiling in lung cancerPeter W Hamilton, Yinhai Wang, Clinton Boyd, et al.
British Journal of Cancer|June 9, 2017
Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapiesMuhammad A Alvi, Maurice B Loughrey, Philip Dunne, et al.
Oncotarget|August 29, 2015
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utilityMuhammad A Alvi, Darragh G McArt, Paul Kelly, et al.
Oncotarget|April 19, 2017
Erythropoietin drives breast cancer progression by activation of its receptor EPORKa Kui Chan, Kyle B Matchett, Jonathan A Coulter, et al.
British Journal of Haematology|October 7, 2014
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementationPerry Maxwell, Florinda Melendez-Rodríguez, Kyle B Matchett, et al.
Pageof 5